November 2020: Oncology
November 16, 2020
In this weeks oncology round-up, we’ve gathered information on the role of long non-coding RNAs in the development of pancreatic cancer, insight into a gene signature in localized prostate cancer, and new applications of cells in cancer therapies.
November 4, 2020 / Duke
Innovative research has shed light on the mysterious role of long non-coding RNAs in the development of pancreatic cancer and suggests potential new targets for precision cancer therapies.
November 9, 2020 / Columbia University
Researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
November 12, 2020 / University of California
When it comes to complex life — that of the multicellular variety — cell death can be just as important as survival. It allows organisms to clean house and prevent the proliferation of damaged cells that could compromise tissue function.
